HRT Financial’s Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share CCV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-25,828
Closed -$4K 3366
2023
Q3
$4K Buy
25,828
+835
+3% +$168 ﹤0.01% 2211
2023
Q2
$4K Hold
24,993
﹤0.01% 2257
2023
Q1
$4K Hold
24,993
﹤0.01% 2318
2022
Q4
$2K Buy
+24,993
New +$1.07K ﹤0.01% 2354

Other funds holding CCV.WS

HRT Financial's CCV.WS Position: Q4 2023 in Review

HRT Financial sold out of Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share (CCV.WS) in Q4 2023, closing a stake of 25,828 shares — an estimated $4K sold.

HRT Financial first reported a position in CCV.WS in Q4 2022 and held it in 4 quarters. The position peaked at $4K in Q3 2023. 1 fund tracked by Wall St. Rank holds CCV.WS as of Q4 2023.

  • HRT Financial reported no remaining Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 25,828 Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q4 2023, an estimated $4K.
  • HRT Financial first reported a position in Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q4 2022 and held it in 4 quarters.
  • HRT Financial's Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $4K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.